NCT04767711View on ClinicalTrials.gov

Prevention of Glucocorticoid Induced Impairment of Bone Metabolism

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 16, 2022

Primary Completion Date

December 15, 2022

Study Completion Date

December 15, 2022

Conditions
Bone Loss
Interventions
DIETARY_SUPPLEMENT

Lactobacillus reuteri ATCC PTA 6475 (L. reuteri 6475)

L.reuteri with cholecalciferol compared to cholecalciferol only.

DRUG

Prednisolone

Oral glucocorticoid 25 mg daily for 7 days.

Trial Locations (1)

43180

Geriatric Medicine, Sahlgrenska University Hospital, Mölndal

Sponsors

Collaborators (1)

BioGaia AB
All Listed Sponsors
collaborator

BioGaia AB

INDUSTRY

lead

Sahlgrenska University Hospital

OTHER

NCT04767711 - Prevention of Glucocorticoid Induced Impairment of Bone Metabolism | Biotech Hunter | Biotech Hunter